Eversept Partners’s CVS Health CVS Stock Holding History

Eversept Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-63,696	Closed	-$5.05M	–	129
2025 Q4	$5.05M	Buy	+63,696	New	+$5.02M	0.25%	70

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners's CVS Position: Q1 2026 in Review

Eversept Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 63,696 shares — an estimated $5.05M sold.

Eversept Partners first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $5.05M in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Eversept Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Eversept Partners sold 63,696 CVS Health shares in Q1 2026, an estimated $5.05M.
Eversept Partners first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
Eversept Partners's CVS Health position peaked at $5.05M in Q4 2025.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.